Related Experiment Video
Updated: Oct 9, 2026

Double Direct Injection of Blood into the Cisterna Magna as a Model of Subarachnoid Hemorrhage
Published on: August 30, 2020
Risk factors for recurrent cerebral amyloid angiopathy-related intracerebral hemorrhage
Xinglei Jia1, Menghan Bo1, Hong Zhao2
1VIP Department, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Insights
Cerebral amyloid angiopathy-related intracerebral hemorrhage (CAA-ICH) recurs in 23% of cases. Risk factors for recurrence include prior hemorrhage, larger initial bleed volume, and specific imaging markers like superficial siderosis.
Area of Science:
- Neurology
- Neurosurgery
- Radiology
Background:
- Cerebral amyloid angiopathy (CAA) is a primary cause of lobar intracerebral hemorrhage (ICH) in older adults.
- The recurrent nature of CAA-related ICH (CAA-ICH) contributes significantly to patient disability and mortality.
- Understanding recurrence rates and risk factors is crucial for managing CAA-ICH.
Conclusions:
- CAA-ICH exhibits a high recurrence rate, underscoring the need for vigilant monitoring and management.
- Cerebral subarachnoid hemorrhage, cortical superficial siderosis (particularly disseminated), and centrum semiovale-perivascular spaces severity are key predictors of recurrent CAA-ICH.
- Identifying these clinical and neuroimaging predictors is vital for improving patient outcomes and prognosis in CAA-ICH.
Background:
Cerebral amyloid angiopathy (CAA) is the most common cause of lobar intracerebral hemorrhage (ICH) in the elderly, and its multifocal and recurrent nature leads to high rates of disability and mortality. Therefore, this study aimed to summarize the evidence regarding the recurrence rate and risk factors for CAA-related ICH (CAA-ICH).
Methods:
We performed a systematic literature search of all English studies published in PubMed, Embase, Web of Science, Cochrane Library, Scopus, and CINAHL from inception to June 10, 2023. Studies reporting CAA-ICH recurrence rates and risk factors for CAA-ICH recurrence were included. We calculated pooled odds ratios (ORs) with their corresponding 95% confidence intervals (CIs) using a random/fixed-effects model based on the I2 assessment of heterogeneity between studies. Publication bias was assessed using Egger's test.
Results:
Thirty studies were included in the final analysis. Meta-analysis showed that the recurrence rate of CAA-ICH was 23% (95% CI: 18-28%, I2 = 96.7%). The risk factors significantly associated with CAA-ICH recurrence were: previous ICH (OR = 2.03; 95% CI: 1.50-2.75; I2 = 36.8%; N = 8), baseline ICH volume (OR = 1.01; 95% CI: 1-1.02; I2 = 0%; N = 4), subarachnoid hemorrhage (cSAH) (OR = 3.05; 95% CI: 1.86-4.99; I2 = 0%; N = 3), the presence of cortical superficial siderosis (cSS) (OR = 2.04; 95% CI: 1.46-2.83; I2 = 0%; N = 5), disseminated cSS (OR = 3.21; 95% CI: 2.25-4.58; I2 = 16.0%; N = 6), and centrum semiovale-perivascular spaces (CSO-PVS) severity (OR = 1.67; 95% CI: 1.14-2.45; I2 = 0%; N = 4).
Conclusion:
CAA-ICH has a high recurrence rate. cSAH, cSS (especially if disseminated), and CSO-PVS were significant markers for recurrent CAA-ICH. The onset of ICH in patients with CAA is usually repeated several times, and recurrence is partly related to the index ICH volume. Identifying clinical and neuroimaging predictors of CAA-ICH recurrence is of great significance for evaluating outcomes and improving the prognosis of patients with CAA-ICH.
Systematic Review Registration:
https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=400240, identifier [CRD42023400240].
Related Concept Videos
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Cerebral Edema ll: Pathophysiology
Cytotoxic Edema: Pathophysiology

